Table 3.
Unsolicited AEs (MedRA term) | NS N (%)* | PfSPZ Vaccine N (%)* |
---|---|---|
Dental and periodontal infections | 1 (6.3%) | 3 (18.8%) |
Ear and labyrinth disorders | 0 (0.0%) | 1 (6.3%) |
Gastrointestinal disorders | 0 (0.0%) | 1 (6.3%) |
General disorders | 3 (18.8%) | 1 (6.3%) |
Infections and infestations | 6 (37.5%) | 8 (50.0%) |
Injury and procedural complications | 2 (12.5%) | 0 (0.0%) |
Musculoskeletal and connective tissue disorders | 3 (18.8%) | 1 (6.3%) |
Nervous system disorders | 0 (0.0%) | 1 (6.3%) |
Skin and subcutaneous tissue disorders | 1 (6.3%) | 0 (0.0%) |
Total number of unsolicited AEs | 16 | 16 |
AE = adverse event; NS = normal saline; PfSPZ = Plasmodium falciparum sporozoites. There were no significant differences in the incidence of unsolicited AEs between recipients of NS and PfSPZ Vaccine. The P values were calculated on a per volunteer basis (e.g. 3/20 vs. 1/10 for dental and periodontal infections) in a two-sided Fisher’s exact test. All P values were ≥ 0.1.
The numbers in brackets are calculated as the proportion of the total unsolicited AEs reported.